OBJECTIVE: Elective abdominal aortic aneurysm (AAA) repair is beneficial when rupture is likely during a patient's expected lifetime. The purpose of this study was to identify predictors of long-term mortality after elective AAA repair for moderately sized AAAs (<6.5-cm diameter) to identify patients unlikely to benefit from surgery. METHODS: We analyzed 2367 elective infrarenal AAA (<6.5 cm) repairs across 21 centers in New England from 2003 to 2011. Our main outcome measure was 5-year life-table survival. Cox proportional hazards analysis was used to describe associations between patient characteristics and 5-year survival. RESULTS: During the study period, 1653 endovascular AAA repairs and 714 open AAA repairs were performed. Overall, 5-year survival rates were similar by procedure type (75% endovascular repair, 80% open repair; P = .14). Advanced age ≥75 years (hazard ratio [HR], 2.0; P < .01) and age >80 years (HR, 2.6; P < .01), coronary artery disease (HR, 1.4; P < .04), unstable angina or recent myocardial infarction (HR, 4.6; P < .01), oxygen-dependent chronic obstructive pulmonary disease (HR, 2.7; P < .01), and estimated glomerular filtration rate <30 mL/min/1.73 m(2) (HR, 2.8; P < .01) were associated with poor survival. Aspirin (HR, 0.8; P < .03) and statin (HR, 0.7; P < .01) use were associated with improved survival. We used these risk factors to develop risk strata for low-risk, medium-risk, and high-risk groups with survival, respectively, of 85%, 69%, and 43% at 5 years (P < .001). CONCLUSIONS: More than 75% of patients with moderately sized AAAs who underwent elective repair in our region survived 5 years, but 4% were at high risk for 5-year mortality. Patients with multiple risk factors, especially age >80 years, unstable angina, oxygen-dependent chronic obstructive pulmonary disease, and estimated glomerular filtration rate <30 mL/min/1.73 m(2), are unlikely to achieve sufficient long-term survival to benefit from surgery, unless their AAA rupture risk is very high.
OBJECTIVE: Elective abdominal aortic aneurysm (AAA) repair is beneficial when rupture is likely during a patient's expected lifetime. The purpose of this study was to identify predictors of long-term mortality after elective AAA repair for moderately sized AAAs (<6.5-cm diameter) to identify patients unlikely to benefit from surgery. METHODS: We analyzed 2367 elective infrarenal AAA (<6.5 cm) repairs across 21 centers in New England from 2003 to 2011. Our main outcome measure was 5-year life-table survival. Cox proportional hazards analysis was used to describe associations between patient characteristics and 5-year survival. RESULTS: During the study period, 1653 endovascular AAA repairs and 714 open AAA repairs were performed. Overall, 5-year survival rates were similar by procedure type (75% endovascular repair, 80% open repair; P = .14). Advanced age ≥75 years (hazard ratio [HR], 2.0; P < .01) and age >80 years (HR, 2.6; P < .01), coronary artery disease (HR, 1.4; P < .04), unstable angina or recent myocardial infarction (HR, 4.6; P < .01), oxygen-dependent chronic obstructive pulmonary disease (HR, 2.7; P < .01), and estimated glomerular filtration rate <30 mL/min/1.73 m(2) (HR, 2.8; P < .01) were associated with poor survival. Aspirin (HR, 0.8; P < .03) and statin (HR, 0.7; P < .01) use were associated with improved survival. We used these risk factors to develop risk strata for low-risk, medium-risk, and high-risk groups with survival, respectively, of 85%, 69%, and 43% at 5 years (P < .001). CONCLUSIONS: More than 75% of patients with moderately sized AAAs who underwent elective repair in our region survived 5 years, but 4% were at high risk for 5-year mortality. Patients with multiple risk factors, especially age >80 years, unstable angina, oxygen-dependent chronic obstructive pulmonary disease, and estimated glomerular filtration rate <30 mL/min/1.73 m(2), are unlikely to achieve sufficient long-term survival to benefit from surgery, unless their AAArupture risk is very high.
Authors: F A Lederle; G R Johnson; S E Wilson; E P Chute; R J Hye; M S Makaroun; G W Barone; D Bandyk; G L Moneta; R G Makhoul Journal: Arch Intern Med Date: 2000-05-22
Authors: H A Ashton; M J Buxton; N E Day; L G Kim; T M Marteau; R A P Scott; S G Thompson; N M Walker Journal: Lancet Date: 2002-11-16 Impact factor: 79.321
Authors: Frank A Lederle; Gary R Johnson; Samuel E Wilson; David J Ballard; William D Jordan; John Blebea; Fred N Littooy; Julie A Freischlag; Dennis Bandyk; Joseph H Rapp; Atef A Salam Journal: JAMA Date: 2002-06-12 Impact factor: 56.272
Authors: Frank A Lederle; Julie A Freischlag; Tassos C Kyriakides; Jon S Matsumura; Frank T Padberg; Ted R Kohler; Panagiotis Kougias; Jessie M Jean-Claude; Dolores F Cikrit; Kathleen M Swanson Journal: N Engl J Med Date: 2012-11-22 Impact factor: 91.245
Authors: William P Robinson; Andres Schanzer; Youfu Li; Philip P Goodney; Brian W Nolan; Mohammad H Eslami; Jack L Cronenwett; Louis M Messina Journal: J Vasc Surg Date: 2012-11-20 Impact factor: 4.268
Authors: Randall R DeMartino; Ying Huang; Jay Mandrekar; Philip P Goodney; Gustavo S Oderich; Manju Kalra; Thomas C Bower; Jack L Cronenwett; Peter Gloviczki Journal: J Vasc Surg Date: 2017-08-12 Impact factor: 4.268
Authors: S S Bahia; P J E Holt; D Jackson; B O Patterson; R J Hinchliffe; M M Thompson; A Karthikesalingam Journal: Eur J Vasc Endovasc Surg Date: 2015-06-23 Impact factor: 7.069
Authors: Hyunwook Kwon; Do Yun Lee; Soo Jin Na Choi; Ki Hyuk Park; Seung-Kee Min; Jeong-Hwan Chang; Seung Huh; Yong Sun Jeon; Jehwan Won; Seung Jae Byun; Sang Jun Park; Lee Chan Jang; Tae-Won Kwon Journal: Vasc Specialist Int Date: 2015-09-30